Edition:
India

Cellectar Biosciences Inc (CLRB.OQ)

CLRB.OQ on NASDAQ Stock Exchange Capital Market

1.19USD
23 Feb 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.19
Open
$1.19
Day's High
$1.19
Day's Low
$1.18
Volume
6,810
Avg. Vol
39,761
52-wk High
$3.06
52-wk Low
$1.07

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.258
Jun '17 0.00 -0.232
Mar '17 0.00 -0.241
FY 2016 Dec '16 0.00 -0.344
Sep '16 0.00 -0.426
Jun '16 0.00 -0.493
Mar '16 0.00 0.910
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Mar-18 1 -0.23 -0.23 -0.23 --
Quarter Ending Jun-18 1 -0.24 -0.24 -0.24 --
Year Ending Dec-18 1 -0.96 -0.96 -0.96 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.10 32.90
P/E High - Last 5 Yrs. -- 40.92 45.97
P/E Low - Last 5 Yrs. -- 23.79 24.37
Beta 1.02 0.90 0.89
Price to Sales (TTM) -- 3.98 5.77
Price to Book (MRQ) 2.13 4.84 5.41
Price to Tangible Book (MRQ) 2.60 5.66 6.98
Price to Cash Flow (TTM) -- 23.02 23.42
% Owned Institutions 7.03 1.25 2.22

Dividends

  Company industry sector
Dividend Yield -- 1.57 1.50
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.33 5.21
Payout Ratio(TTM) -- 45.86 43.73

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 3.67 9.24
Sales (TTM) vs TTM 1 Yr. Ago -- 4.72 5.59
Sales - 5 Yr. Growth Rate -- 10.02 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 52.94 16.65 19.66
EPS (TTM) vs TTM 1 Yr. Ago -33.17 -- --
EPS - 5 Yr. Growth Rate -- 9.82 10.73
Capital Spending - 5 Yr. Growth Rate -9.41 15.22 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) 5.88 2.89 2.97
LT Debt to Equity (MRQ) 0.03 9.91 12.22
Total Debt to Equity (MRQ) 0.06 13.93 16.52
Interest Coverage (TTM) -- 36.27 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.11 54.70
Gross Margin - 5 Yr. Avg. -- 52.40 52.42
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.51 10.86
Operating Margin (TTM) -- 14.36 4.64
Operating Margin - 5 Yr. Avg. -- 14.42 6.26
Pre-Tax Margin (TTM) -- 14.77 5.44
Pre-Tax Margin - 5 Yr. Avg. -- 14.73 6.60
Net Profit Margin (TTM) -- 11.05 1.76
Net Profit Margin - 5 Yr. Avg. -- 11.07 2.91
Effective Tax Rate (TTM) -- 23.16 23.04
Effective Tax Rate - 5 Yr. Avg. -- 23.41 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 948,744,532 855,673,508
Net Income/Employee (TTM) -725,656 111,622,899 100,656,226
Receivable Turnover (TTM) -- 5.62 5.78
Inventory Turnover (TTM) -- 2.58 3.35
Asset Turnover (TTM) 0.00 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -90.79 11.45 10.98
Return on Assets - 5 Yr. Avg. -75.22 12.98 12.37
Return on Investment (TTM) -103.68 14.91 14.43
Return on Investment - 5 Yr. Avg. -115.63 16.98 16.18
Return on Equity (TTM) -105.20 16.41 16.13
Return on Equity - 5 Yr. Avg. -127.41 18.08 17.47
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 80.61 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cellectar Biosciences Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 13.69%
# of Holders: 23
Total Shares Held: 2,164,961
3 Mo. Net Change: 1,287,483
# New Positions: 7
# Closed Positions: 1
# Increased Positions: 11
# Reduced Positions: 1
# Net Buyers: 10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.